Overview
- 21 inspections across 20 sites are on record.
- 35 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-30.
At a glance
Inspections
21
Sites
20
Observations
35
Career since
Oct 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| CIMBAR PERFORMANCE MINERALS, INC. | 30 Jan 2020 | Human Drugs | |
| Acella Pharmaceuticals, LLC | 7 Jan 2020 | Human Drugs | On file |
| Alliant Pharmaceutical Services, LLC | 7 Jan 2020 | Human Drugs | |
| Hospira, Inc. | 21 Nov 2019 | Human Drugs | View 483 → |
| Alexion Pharmaceuticals Inc. | 23 Oct 2019 | Animal Drugs & Feeds |
Sites inspected
CIMBAR PERFORMANCE MINERALS, INC.Chatsworth, United States1 insp.
Acella Pharmaceuticals, LLCAlpharetta, United States1 insp.
Alliant Pharmaceutical Services, LLCAlpharetta, United States1 insp.
Hospira, Inc.Rocky Mount, United States1 insp.
Alexion Pharmaceuticals Inc.Bogart, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Veronica Fuentes3 shared
Adam R Cooke2 shared
Carlos M Gonzalez1 shared
Johnetta F Walters1 shared
Carol F Robinson1 shared
Sonya M Edmonds1 shared
Rachael L Cook1 shared
Seneca D Toms1 shared
Tajah L Blackburn1 shared
Bonita S Chester1 shared
Full investigator report
Get the verbatim findings behind Gideon N Esuzor's 35 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site